Inactivating mutations or deletions in the negative regulator phosphatase and tensin homolog (PTEN), PI3K subunits, or AKT1 have been extensively described in pediatric T-ALL patients.84 Specifically, the role of PTEN in GC resistance is still debated in the scientific community. This evidence concerns the gene AKT1 and acute lymphoblastic leukemia.